Highlights Spectral Medical Inc.

Equities

EDT

CA8475771033

Market Closed - Toronto S.E. Other stock markets 01:30:00 16/05/2024 am IST			5-day change	1st Jan Change
0.53 ^CAD	+3.92%		+17.78%	+24.71%

13/05	Spectral Medical Q1 Loss Widens, Says Tigris Trial Enrollment Reaches 106 Patients	MT
13/05	Spectral Medical Brief: Loss for the three-months ended March 31, 2024 was $4,160,000 ($0.01 per share)	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Spectral Medical Q1 Loss Widens, Says Tigris Trial Enrollment Reaches 106 Patients	13/05	MT
Spectral Medical Brief: Loss for the three-months ended March 31, 2024 was $4,160,000 ($0.01 per share)	13/05	MT
Spectral Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05	CI
Spectral Medical Says 105 Patients Now Enrolled in Tigris Trial	06/05	MT
Spectral Medical Brief: Providing April Tigris Trial Update; 105 patients enrolled; Says April represents a record breaking month for patient enrollment	06/05	MT
Spectral Medical Inc. Provides Tigris Trial Update	06/05	CI
Spectral Medical Updated on Tigris Trial	10/04	MT
Spectral Medical Brief: Providing Tigris Trial Update; 101 patients enrolled	10/04	MT
Spectral Medical Provides Tigris Trial Update	10/04	CI
Spectral Medical Brief: Says Total of 97 patients randomized to date out of the 150 total patients to be enrolled in the Tigris trial	29/03	MT
Spectral Medical Brief: Q4 Revenue $365,000; Loss was $6,479,000, or $0.02 per share	29/03	MT
Spectral Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03	CI
North American Morning Briefing : Stocks Struggle After New Records	22/03	DJ
Spectral Medical Inc. Provides Update on the Company's Tigris Trial	28/02	CI
Spectral Medical Says PMX Distribution and Supply Agreement with Baxter International Extended for 10 Years	22/02	MT
Spectral Medical Brief: Baxter to act as Exclusive partner to Spectral for 10 years following PMX approval by U.S. FDA	22/02	MT
Spectral Medical Brief: Announcing Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare Corporation	22/02	MT
Spectral Medical Inc. Announces Amendment and Extension of Exclusive Supply and Distribution Agreement with Baxter Healthcare Corporation	22/02	CI
Spectral Medical Announcing "Major Milestone" by Reaching Its Interim Enrollment Target of 90 Patients	15/02	MT
Spectral Medical Brief: Announcing "Major Milestone" by Reaching Its Interim Enrollment Target of 90 Patients	15/02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Spectral Medical Inc.

Equities

EDT

CA8475771033

Highlights

Filters